
SEC exempt reporting adviser
Readout Capital
Readout Capital is a biotech-focused investment firm led by two co-founders, one handling investment decisions and the other scientific and medical diligence.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Readout Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Readout Capital joined, from press and the firm’s own posts.
Every round Readout Capital joined
Round sizes, Readout Capital’s role and who invested alongside.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Readout Capital
Events where Readout Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Readout Capital is based in the United States.
3 fund vehicles are on public registers (SEC adviser filings), including ROC HOLDINGS SPV I, LP, READOUT CAPITAL MASTER FUND, LP and ROC HOLDINGS SPV II.
Sectors: Biotech. From the firm’s own website.
Know before Readout Capital’s next round is announced.
PRO tracks Readout Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.